Paper17877482
New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma.
Kudo M. Hepatol Res, 2007. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Papers, record 17877482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17877482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39583507 | Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques. | Cureus | 2024 | https://conductscience.org/library/papers/39583507 | PubMed |
| 37901198 | Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy. | Liver Cancer | 2023 | https://conductscience.org/library/papers/37901198 | PubMed |
| 35322130 | Serum Folate deficiency in HCV related Hepatocellular Carcinoma. | Sci Rep | 2022 | https://conductscience.org/library/papers/35322130 | PubMed |
| 32874864 | The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. | J Med Ultrasound | 2020 | https://conductscience.org/library/papers/32874864 | PubMed |
| 32447876 | The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. | Ultrasonography | 2020 | https://conductscience.org/library/papers/32447876 | PubMed |
| 32062622 | The Efficacy of Sonazoid-enhanced Ultrasonography in Decision-making for Liver Abscess Treatment. | Intern Med | 2020 | https://conductscience.org/library/papers/32062622 | PubMed |
| 27278700 | Quantification of tumor vascularity with contrast-enhanced ultrasound for early response of transcatheter arterial chemoembolization for hepatocellular carcinoma: a report of three cases. | J Med Ultrason (2001) | 2012 | https://conductscience.org/library/papers/27278700 | PubMed |
| 26694825 | Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience. | J Gastroenterol | 2016 | https://conductscience.org/library/papers/26694825 | PubMed |
| 26576571 | Characterization of the biliary tract by virtual ultrasonography constructed by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. | J Med Ultrason (2001) | 2015 | https://conductscience.org/library/papers/26576571 | PubMed |
| 24764654 | Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24764654 | PubMed |
| 24133386 | Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma. | Radiol Oncol | 2013 | https://conductscience.org/library/papers/24133386 | PubMed |
| 23935709 | Mucinous cystadenocarcinoma of the appendix in which contrast-enhanced ultrasonography was useful for assessing blood flow in a focal nodular lesion in the tumor cavity: A case report. | Exp Ther Med | 2013 | https://conductscience.org/library/papers/23935709 | PubMed |
| 23837029 | Arrival time parametric imaging using Sonazoid-enhanced ultrasonography is useful for the detection of spoke-wheel patterns of focal nodular hyperplasia smaller than 3 cm. | Exp Ther Med | 2013 | https://conductscience.org/library/papers/23837029 | PubMed |
| 22966329 | Evaluation of contrast-enhanced ultrasonography using perfluorobutane (Sonazoid(®)) in patients with small hepatocellular carcinoma: comparison with dynamic computed tomography. | Oncol Lett | 2010 | https://conductscience.org/library/papers/22966329 | PubMed |
| 22200940 | Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. | J Gastroenterol | 2012 | https://conductscience.org/library/papers/22200940 | PubMed |
| 22174544 | Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/22174544 | PubMed |
| 21160724 | Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinoma. | World J Radiol | 2009 | https://conductscience.org/library/papers/21160724 | PubMed |
| 21160664 | Hepatic malignancies: Correlation between sonographic findings and pathological features. | World J Radiol | 2010 | https://conductscience.org/library/papers/21160664 | PubMed |
| 19148804 | Multistep human hepatocarcinogenesis: correlation of imaging with pathology. | J Gastroenterol | 2009 | https://conductscience.org/library/papers/19148804 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17877482
GET https://conductscience.org/api/papers/v1/17877482/authors